Alaunos Therapeutics reported $2.68M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Amgen USD 29.06B 1.17B Dec/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Baxter International USD 6.87B 61M Dec/2025
Biogen USD 8.97B 37.5M Dec/2025
Bioline Rx USD 28.52M 3.34M Sep/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Celltrion KRW 5.54T 291.68B Sep/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Curis USD 6.92M 7.5M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 409.44M 4.39M Dec/2025
Divis Laboratories Ltd INR 98.43B 2.38B Sep/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
GlaxoSmithKline GBP 17.51B 332M Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
Intrexon USD 23.72M 45.04M Jun/2024
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Kangmei Pharma CNY 7.03B 128.34M Sep/2025
Karyopharm Therapeutics USD 103.15M 13.4M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Novartis USD 30.46B 2.26B Dec/2025
Organigram Holdings CAD 256.54M 28.35M Dec/2025
Ovoca Bio EUR 1.56M 3.39M Jun/2025
Pfizer USD 46.92B 3.22B Sep/2025
Pharma Mar EUR 283.41M 40.53M Dec/2025
PTC Therapeutics USD 2.27B 266.14M Dec/2025
Qiagen NV USD 2B 535.87M Dec/2025
Regeneron Pharmaceuticals USD 18.02B 41.2M Dec/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sartorius EUR 1.72B 449M Sep/2025
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
TG Therapeutics USD 630.76M 31M Dec/2025
Tilray USD 729.32M 28.18M Sep/2025
Verastem USD 223.41M 69.36M Dec/2025
Zealand Pharma A/S 15.67B 950.94M Dec/2025
Zz Pientze Pharmaceu CNY 10.7B 1.59B Sep/2025